Diabetes drug shows promise against deadly brain tumors
Disease control
Not yet recruiting
This early-phase trial tests whether sitagliptin, a common diabetes medicine, can help treat a severe type of brain cancer (grade 4 glioma) that has returned after standard treatment. About 45 adults will receive sitagliptin along with the standard drug bevacizumab. The study aim…
Phase: PHASE1 • Sponsor: Kailin Yang, MD, PhD • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC